三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
BAT8006的中位无进展生存期(mPFS)为7.47个月
BAT8006的中位无进展生存期(mPFS)为7.47个月
其它
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:186KB
图片尺寸:1141*918
同报告图片
/
4
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
所属报告:
百奥泰-公司深度报告:进入兑现期的生物类似药领跑者-240710(33页).pdf
打包全文图表
相关数据
图表12一线尿路上皮癌不同疗法mPFS(月)对比
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
收藏
行业数据
2026-02-28
原图定位
查看详情
图表14一线TNBC不同疗法mPFS(月)对比
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
收藏
行业数据
2026-02-28
原图定位
查看详情
SI-B001针对PD-(L1)抑制剂治疗失败的野生型NSCLC的mPFS数据
fCDliIbnu4QgICAgICAgICAgICAgICAgICAgICB8IOS6i+S7ti8gTiB8IOaciOS4reS9jeaVsO+8iDk1JSBDSe+8iSB8IDbkuKrmnIjml6Dov5vlsZXnlJ/lrZjnjofvvIg5NSUgQ0nvvIkgfAp8LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18CnwgQuW6j+WIlzE2KzltZy9rZyBRVyAgICAgICAgfCAxMS8yMyAgIHwgNS42ICg0LjEsIC4pICAgICAgIHwgNDQlICgyMSwgNjgpICAgICAgICAgICAgICAgfAp8IOaXoEFHQSAgICAgICAgICAgICAgICAgICAgfCA4LzE5ICAgIHwgNy4yICg0LjMsIC4pICAgICAgIHwgNTIlICgyNiwgNzkpICAgICAgICAgICAgICAgfAp8IOaciUFHQSAgICAgICAgICAgICAgICAgICAgfCAzLzQgICAgIHwgMyAoMS40LCAuKSAgICAgICAgIHwgMCUgKDEsIDk5KSAgICAgICAgICAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77ya5riv6IKh5oub6IKh5Lmm77yM55Sz5LiH5a6P5rqQ56CU56m2
收藏
行业数据
2025-12-26
原图定位
查看详情
HARMONi-6在全人群及各个亚组中均展现显著mPFS获益
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
收藏
行业数据
2025-10-23
原图定位
查看详情
针对肝癌目前1L/2L治疗方案的ORR较低,mPFS较短,依帕戈替尼(ABSK011)有望改变这一状况
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
收藏
行业数据
2025-10-10
原图定位
查看详情
OptiTROP-Lung03研究ORR及mPFS数据
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
收藏
行业数据
2025-06-30
原图定位
查看详情
D+EP方案在mPFS上与EP方案基本持平
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
收藏
行业数据
2025-05-13
原图定位
查看详情
HS-20093mPFS数据优异
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
收藏
行业数据
2025-05-13
原图定位
查看详情
图表11一线TNBC不同疗法mPFS(月)对比
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
收藏
行业数据
2023-11-20
原图定位
查看详情
图表9一线尿路上皮癌不同疗法mPFS(月)对比
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
收藏
行业数据
2023-11-20
原图定位
查看详情
Opdualag联合疗法对比纳武利尤单药在一线晚期黑色素瘤中mPFS数据
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
收藏
行业数据
2023-05-08
原图定位
查看详情
图表5PD-1+化疗联合疗法mPFS(月)对比
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
收藏
行业数据
2023-04-11
原图定位
查看详情
图表9EGFR-TKI二线mPFS对比(月)
fCDpobnnm64gICAgICAgICB8IOaVsOaNriAgfAp8LS0tLS0tLS0tLS0tLS18LS0tLS0tLXwKfCDotJ3npo/mm7/lsLwgICAgIHwgMTYuNiAgfAp8IOmYv+e+juabv+WwvCAgICAgfCAxMi40ICB8CnwgTGF6ZXJ0aW5pYiAgIHwgMTEuMCAgfAp8IOWlpeW4jOabv+WwvCAgICAgfCAxMC4xICB8Cnwg5LyP576O5pu/5bC8ICAgICB8IDkuNiAgIHwKCui1hOaWmeadpea6kO+8muWMu+iNr+mtlOaWue+8jOWNjuWIm+ivgeWIuA==
收藏
行业数据
2023-03-28
原图定位
查看详情
图表7EGFR-TKI一线mPFS对比(月)
fCDpobnnm64gICAgICAgICB8IOaVsOaNriAgfAp8LS0tLS0tLS0tLS0tLS18LS0tLS0tLXwKfCDotJ3npo/mm7/lsLwgICAgIHwgMjIuMSAgfAp8IOS8j+e+juabv+WwvCAgICAgfCAyMC44ICB8CnwgTGF6ZXJ0aW5pYiAgIHwgMjAuNiAgfAp8IOmYv+e+juabv+WwvCAgICAgfCAxOS4zICB8Cnwg5aWl5biM5pu/5bC8ICAgICB8IDE4LjkgIHwKCui1hOaWmeadpea6kO+8muWMu+iNr+mtlOaWue+8jOWNjuWIm+ivgeWIuA==
收藏
行业数据
2023-03-28
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
BAT8006 I 期数据彰显全人群优势。BAT8006 具有高效的抗肿瘤活性,毒素小分子有很强的细胞膜渗透能力,在 ADC 杀伤癌细胞后能释放并杀死附近的癌细胞,产生旁观者效应,有效克服肿瘤细胞的异质性。根据 ASCO公布的 I期数据,截至 2024年 5月 8日,共54 例受试者已进行至少一次肿瘤评估。有效性方面:在全人群中,包含未确认的部分缓解(PR)病例的 ORR 为 37.0%。在 FRα<50%、FRα≥50%和 FRα≥75%人群中,ORR 分别为33.3%、39.4%和 46.7%。在中位随访 6.5个月时,中位缓解持续时间(DOR)为 6.3个月,中位无进展生存期(mPFS)为 7.47个月。在 6个月、1年时的总生存率分别为 83.0%、83.0%。安全性方面:未见间质性肺疾病或明显的眼部毒性。对比不同 FRα 表达水平的人群:在TPS≥75%的高表达人群中,索米妥昔单抗、Luveltamab Tazevibulin和 BAT8006的 ORR分别为 42.3%、40.0%和 46.7%。在 TPS≥50%的人群中,Luveltamab Tazevibulin和 BAT8006的 ORR分别为 33.3%和 39.4%,BAT8006表现出在更广泛人群中的优势。
其它
原图定位
当前图表所属:
百奥泰-公司深度报告:进入兑现期的生物类似药领跑者-240710(33页).pdf
中国靶向IL23/IL12药物研发竞争格局
全球托珠单抗竞争格局(仅统计临床III期以上)
中国托珠单抗类似药研发竞争格局佳(2款上市,2款NDA,2款I期)
中国贝伐珠单抗研发竞争格局(仅统计已上市或递交上市申请管线)
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》